Homeopathic Market Doesn't 'Disappear' – FDA Forced To Act
Executive Summary
"This was an area that the agency thought was just going to disappear on its own," says Freddie Ann Hoffman, who chaired FDA homeopathic working group that helped develop CPG adopted in 1988 to allow sales of homeopathics to continue without pre-market approval.
You may also be interested in...
Homeopathic Firm Rebrands As Hyland’s Naturals With Shift To Focus On Supplement Market
Hyland’s Naturals focused for nearly 120 years on providing consumer health products in the pediatric and general wellness categories and is expanding into the women’s health and pet categories. Also will launch more than 20 natural wellness products over the next year.
More US COVID-19 Warnings: India Homeopathy Clinic, California Colloidal Silver Seller
Dr. Dhole’s Sushanti gets US FDA warning for claiming homeopathy could keep COVID-19 "under control" while Honey Colony is latest colloidal silver supplement marketer warned about claiming the products could prevent the disease.
US Health Market In 2019: Unfinished Business Leaves Lasting Impression
Examples of unfinished business from 2019 include no legislation passed to reform OTC monograph program; FDA putting off until May the planned publication of an NPRM to allow firms to submit OTC NDAs with extra-label information to help guide consumers' self-selection; and no OTC naloxone for opioid overdose approved even after FDA's unprecedented step of developing model DFLs sponsors could use for their own label comprehension studies.